Clinical trial

Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer

NCT02501759

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention 3 Tesla Magnetic Resonance Imaging Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Gadodiamide Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Multiparametric Magnetic Resonance Imaging Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Transrectal Biopsy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Ultrasound-Guided Prostate Biopsy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer

Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2015-05-01

PhaseNA

Conditions

Health Status Unknownunresolved

Prostate Carcinomaverified · MONDO: prostate carcinoma

Interventions

3 Tesla Magnetic Resonance ImagingPROCEDURE

GadodiamideRADIATION

Multiparametric Magnetic Resonance ImagingPROCEDURE

Transrectal BiopsyPROCEDURE

Ultrasound-Guided Prostate BiopsyPROCEDURE

Sponsors & collaborators

OHSU Knight Cancer Institutelead sponsor

Medical Research Foundation, Oregoncollaborator

National Cancer Institute (NCI)collaborator

Mapped research locations

PortlandOregon, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02501759 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.